Update on brain tumor imaging

Brain tumor imaging has evolved from a strictly morphologybased discipline to one that encompasses function, physiology, and anatomy, enabled by advances in imaging and computer technology. This review outlines the current imaging standard for patients with brain tumors and summarizes the latest advances in physiology-based imaging methods that complement traditional brain tumor imaging protocol. Emphasis is placed on the strengths and limitations of the current imaging standards and on an overview of several advanced imaging methods, including diffusion-weighted magnetic resonance imaging, perfusion magnetic resonance imaging, and proton magnetic resonance spectroscopic imaging. Basic physical principles behind each imaging method are briefly presented, along with a more in-depth discussion of the clinical applications and potential pitfalls of each technique.

[1]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[2]  R R Edelman,et al.  Echo-planar MR imaging. , 1994, Radiology.

[3]  K. Plate,et al.  VEGF in Brain Tumors , 2000, Journal of Neuro-Oncology.

[4]  M Takahashi,et al.  Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. , 1999, Journal of computer assisted tomography.

[5]  Andrei I Holodny,et al.  Diffusion imaging in brain tumors. , 2002, Neuroimaging clinics of North America.

[6]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[7]  F Ståhlberg,et al.  Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. , 2000, AJNR. American journal of neuroradiology.

[8]  T. Tali,et al.  Diagnostic value of contrast-enhanced fluid-attenuated inversion recovery MR imaging of intracranial metastases. , 2004, AJNR. American journal of neuroradiology.

[9]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[10]  P. Burger,et al.  Histologic factors of prognostic significance in the glioblastoma multiforme , 1980, Cancer.

[11]  M. Castillo,et al.  Diffusion-weighted imaging in the evaluation of intracranial lesions. , 2000, Seminars in ultrasound, CT, and MR.

[12]  Ying Lu,et al.  Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients , 2002, Journal of magnetic resonance imaging : JMRI.

[13]  Susumu Mori,et al.  Diffusion tensor brain imaging and tractography. , 2002, Neuroimaging clinics of North America.

[14]  P. Ricci.  Imaging of adult brain tumors. , 1999, Neuroimaging clinics of North America.

[15]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[16]  M Takahashi,et al.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.

[17]  P. Kleihues,et al.  Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors , 2000, Toxicologic pathology.

[18]  C. Claussen,et al.  Brain tumors: MR imaging with gadolinium-DTPA. , 1985, Radiology.

[19]  M. Menger,et al.  Vascular Microenvironment in Gliomas , 2000, Journal of Neuro-Oncology.

[20]  B. Drayer,et al.  Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? , 1998, AJNR. American journal of neuroradiology.

[21]  R. Gonzalez,et al.  Diffusion-weighted MR imaging of the brain. , 2000, Radiology.

[22]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[23]  G. Johnson,et al.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. , 2001, AJNR. American journal of neuroradiology.

[24]  W P Dillon,et al.  Radiation injury of the brain. , 1991, AJNR. American journal of neuroradiology.

[25]  B A Kall,et al.  Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. , 1987, Mayo Clinic proceedings.

[26]  S W Atlas,et al.  Subarachnoid space disease: diagnosis with fluid-attenuated inversion-recovery MR imaging and comparison with gadolinium-enhanced spin-echo MR imaging--blinded reader study. , 1998, Radiology.

[27]  Glyn Johnson,et al.  High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. , 2002, Radiology.

[28]  B. Rosen,et al.  Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd(DTPA) , 1992, Magnetic resonance in medicine.

[29]  D. Atkinson,et al.  Fluid-attenuated inversion recovery (FLAIR): clinical prospectus of current and future applications. , 1996, Topics in magnetic resonance imaging : TMRI.